Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.
Las Condes Clinic, Estoril 450, Las Condes, Santiago, Chile.
J Cancer Res Clin Oncol. 2023 Jul;149(8):4701-4717. doi: 10.1007/s00432-022-04391-6. Epub 2022 Oct 12.
Extracellular vesicles (EV) secreted from cancer cells are present in various biological fluids, carrying distinctly different cellular components compared to normal cells, and have great potential to be used as markers for disease initiation, progression, and response to treatment. This under-utilised tool provides insights into a better understanding of prostate cancer.
EV from serum and urine of healthy men and castration-resistant prostate cancer (CRPC) patients were isolated and characterised by transmission electron microscopy, particle size analysis, and western blot. Proteomic and cholesterol liquid chromatography-mass spectrometry (LC-MS) analyses were conducted.
There was a successful enrichment of small EV/exosomes isolated from serum and urine. EV derived from biological fluids of CRPC patients had significant differences in composition when compared with those from healthy controls. Analysis of matched serum and urine samples from six prostate cancer patients revealed specific EV proteins common in both types of biological fluid for each patient.
Some of the EV proteins identified from our analyses have potential to be used as CRPC markers. These markers may depict a pattern in cancer progression through non-invasive sample collection.
癌细胞分泌的细胞外囊泡(EV)存在于各种生物体液中,与正常细胞相比,其携带的细胞成分明显不同,具有作为疾病起始、进展和治疗反应标志物的巨大潜力。这种未充分利用的工具为更好地了解前列腺癌提供了线索。
通过透射电子显微镜、颗粒大小分析和 Western blot 从健康男性和去势抵抗性前列腺癌(CRPC)患者的血清和尿液中分离和表征 EV。进行蛋白质组学和胆固醇液相色谱-质谱(LC-MS)分析。
成功地从血清和尿液中富集了小 EV/外泌体。与健康对照组相比,来自 CRPC 患者生物体液的 EV 在组成上有明显差异。对 6 名前列腺癌患者的配对血清和尿液样本进行分析,发现每个患者的两种生物体液中都存在特定的 EV 蛋白。
我们分析中鉴定的一些 EV 蛋白有可能成为 CRPC 的标志物。这些标志物可能通过非侵入性样本采集描绘癌症进展的模式。